Home - PetMedix

ELEVATING EXPECTATIONS
IN PET CARE

PetMedix is delivering the next generation of proven monoclonal antibody technology to provide unprecedented therapeutic options for pets.

OUR STORY

PetMedix leverages an experienced scientific team and decades of human clinical research to develop fully species-specific, naturally generated therapeutic antibodies for pets. Here are some key moments in the company’s development and growth.

March 2014

PetMedix founder, Prof Allan Bradley FRS, publishes complete humanization of the mouse immunoglobulin locus in Nature

September 2017

PetMedix founder, Dr Jolyon Martin, publishes first comprehensive annotation of canine immunoglobulin loci in Immunogenetics

November 2017

Completion of PhD project adapting the transgenic platform from human to canine at Wellcome Sanger Institute

January 2018

Formation of PetMedix as a company

January 2019

Size of company: 12 staff

February 2019

£8million series A funding secured

February 2019

Shortlisted to present at the Animal Health Investment Europe Innovation Showcase

April 2019

Dr Fabian Kausche and Dr Cindy Cole join the Board of Directors

August 2019

Presented at Kansas City Investment Forum on future solutions for pet health

December 2019

Dr Dave Lowery joins the company

January 2020

Size of company: 24 staff

February 2020

Animal Pharm 'Best Start-up 2019' award winner

April 2020

Move to Babraham Research Campus

May 2020

Funding from Cambridge Innovation Capital secured

June 2020

Judged as ‘One to Watch’ in the global Nature Spinoff Awards

October 2020

Size of company: 32 staff

November 2020

Dr Amy Li, PetMedix’s head of Research and Innovation named in Movers and Shakers in BioBusiness 2020 report

January 2021

PetMedix enters into partnership with Boehringer Ingelheim

April 2021

Dr Jolyon Martin, co-Founder and Head of Business Development, named in Forbes 30 under 30 Europe List for Science and Healthcare 2021

June 2021

PetMedix completes Ky9 platform

July 2021

PetMedix antibodies outperform benchmarks in canine study

September 2021

Dr Amy Li, PetMedix head of Research and Development, reveals secrets of DNA methylation in early development

September 2021

PetMedix raises $37M Series B

January 2022

PetMedix enters into antibody discovery collaboration with Zoetis

July 2022

PetMedix founders develop novel antibody sequencing protocol and use it to investigate canine lymphoma

December 2022

Grant of first PetMedix Patent

August 2023

PetMedix is acquired by Zoetis, the world’s biggest animal health pharma company

Welcome to PetMedix

Step into our research hub and meet some of our talented team

This footage was filmed in November 2020

Latest News

Twitter feed is not available at the moment.

Cookie	Duration	Description
cookielawinfo-checkbox-advertisement	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
CookieLawInfoConsent	1 year	Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
elementor	never	This cookie is used by the website's WordPress theme. It allows the website owner to implement or change the website's content in real-time.
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Cookie	Duration	Description
_ga	2 years	The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_gat_gtag_UA_10020327_15	1 minute	Set by Google to distinguish users.
_gid	1 day	Installed by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.

ELEVATING EXPECTATIONS
IN PET CARE